Inhibition of human mast cell activation with the novel selective adenosine A2B receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)22Abbreviations: cAMP, cyclic, AMP; DPCPX, 1,3-dipropyl-8-cyclopentylxanthine; DPSPX, 1,3-dipropyl-8-p-sulfophenylxanthine; FBS, fetal bovine serum; IB-MECA, N6 -(3-iodobenzyl)-N-methyl-5′-carbamoyladenosine; IL-8, interleukin-8; IPDX, 3-isobutyl-8-pyr,5rolidinoxanthine; NECA, 5′-N-ethylcarboxamidoadenosine; PDE, 3′,5′-cyclic nucleotide phosphodiesterase; SAR, structure-activity relationship.

Igor Feoktistov, Emily M. Garland, Anna E. Goldstein, Dewan Zeng, Luiz Belardinelli, Jack N. Wells, Italo Biaggioni

Open source

DOI: 10.1016/s0006-2952(01)00765-1
Published: 2001-11
Container: Biochemical Pharmacology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0006-2952-01-00765-1,
  title = {Inhibition of human mast cell activation with the novel selective adenosine A2B receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)22Abbreviations: cAMP, cyclic, AMP; DPCPX, 1,3-dipropyl-8-cyclopentylxanthine; DPSPX, 1,3-dipropyl-8-p-sulfophenylxanthine; FBS, fetal bovine serum; IB-MECA, N6 -(3-iodobenzyl)-N-methyl-5′-carbamoyladenosine; IL-8, interleukin-8; IPDX, 3-isobutyl-8-pyr,5rolidinoxanthine; NECA, 5′-N-ethylcarboxamidoadenosine; PDE, 3′,5′-cyclic nucleotide phosphodiesterase; SAR, structure-activity relationship.},
  author = {Igor Feoktistov and Emily M. Garland and Anna E. Goldstein and Dewan Zeng and Luiz Belardinelli and Jack N. Wells and Italo Biaggioni},
  year = {2001},
  journal = {Biochemical Pharmacology},
  doi = {10.1016/s0006-2952(01)00765-1},
  url = {https://doi.org/10.1016/s0006-2952(01)00765-1}
}

RIS

TY  - JOUR
TI  - Inhibition of human mast cell activation with the novel selective adenosine A2B receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)22Abbreviations: cAMP, cyclic, AMP; DPCPX, 1,3-dipropyl-8-cyclopentylxanthine; DPSPX, 1,3-dipropyl-8-p-sulfophenylxanthine; FBS, fetal bovine serum; IB-MECA, N6 -(3-iodobenzyl)-N-methyl-5′-carbamoyladenosine; IL-8, interleukin-8; IPDX, 3-isobutyl-8-pyr,5rolidinoxanthine; NECA, 5′-N-ethylcarboxamidoadenosine; PDE, 3′,5′-cyclic nucleotide phosphodiesterase; SAR, structure-activity relationship.
AU  - Igor Feoktistov
AU  - Emily M. Garland
AU  - Anna E. Goldstein
AU  - Dewan Zeng
AU  - Luiz Belardinelli
AU  - Jack N. Wells
AU  - Italo Biaggioni
PY  - 2001
JO  - Biochemical Pharmacology
DO  - 10.1016/s0006-2952(01)00765-1
UR  - https://doi.org/10.1016/s0006-2952(01)00765-1
ER  -

APA

Feoktistov, I., Garland, E. M., Goldstein, A. E., Zeng, D., Belardinelli, L., Wells, J. N., & Biaggioni, I. (2001). Inhibition of human mast cell activation with the novel selective adenosine A2B receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)22Abbreviations: cAMP, cyclic, AMP; DPCPX, 1,3-dipropyl-8-cyclopentylxanthine; DPSPX, 1,3-dipropyl-8-p-sulfophenylxanthine; FBS, fetal bovine serum; IB-MECA, N6 -(3-iodobenzyl)-N-methyl-5′-carbamoyladenosine; IL-8, interleukin-8; IPDX, 3-isobutyl-8-pyr,5rolidinoxanthine; NECA, 5′-N-ethylcarboxamidoadenosine; PDE, 3′,5′-cyclic nucleotide phosphodiesterase; SAR, structure-activity relationship.. Biochemical Pharmacology. https://doi.org/10.1016/s0006-2952(01)00765-1

Source records

crossref · retrieved 2026-09-26T12:58:53.437Z